Jinhua People’s Hospital has performed its first‑ever HIPEC treatment, opening up new hope for patients with abdominal cavity tumors

Breaking the Dilemma of Advanced Abdominal Tumors

Abdominal tumors complicated by peritoneal metastasis remain a key focus and major challenge in clinical oncology. These patients often have hidden micrometastases and free cancer cells that are difficult to eradicate. Traditional surgery combined with systemic chemotherapy struggles to completely clear residual tumor cells in the abdominal cavity, leading to high recurrence rates and low long-term survival.

To break through this treatment dilemma and help hospitals enhance comprehensive oncology care, our Body Cavity Hyperthermic Perfusion Therapy Machine has been successfully installed at Jinhua People's Hospital (Affiliated Jinhua Hospital of Wenzhou Medical University). This assisted the hospital's Gastrointestinal and Hernia Surgery Department in successfully completing its first Hyperthermic Intraperitoneal Chemotherapy (HIPEC) procedure, marking the hospital's entry into a new era of precise, standardized, and comprehensive treatment for abdominal tumors.

Two Successful Clinical Cases Validate the Hardcore Strength of HIPEC Technology

Case 1: First HIPEC Treatment a Complete Success (70+ Year-Old with Appendiceal Mucinous Neoplasm)

Aunt Wang was admitted with recurrent abdominal pain and diarrhea. Diagnostics revealed a space-occupying lesion in the ileocecal junction. Due to the high risk of peritoneal seeding associated with appendiceal mucinous neoplasms, a multidisciplinary team (MDT) decided on a comprehensive approach. The surgical team successfully performed a single-port laparoscopic right hemicolectomy, followed by standard HIPEC treatment using our equipment. The 60-minute continuous perfusion safely and precisely eradicated invisible micrometastases. After 3 standard HIPEC sessions, she recovered well and was discharged on day 10.

Case 2: Comprehensive Treatment Controls Advanced Bowel Cancer with Peritoneal Metastasis (77-Year-Old Patient)

Uncle Xu suffered from recurrent abdominal pain and distension for 5 months. Imaging indicated incomplete bowel obstruction, ascites, and extensive peritoneal thickening. After an emergency laparoscopic biopsy confirmed adenocarcinoma with extensive peritoneal metastasis, the team formulated an individualized plan: Cytoreductive Surgery (CRS) + HIPEC + Systemic Therapy. Uncle Xu's condition is now effectively controlled, allowing him to genuinely experience the survival benefits of precise oncology treatment.

Hardcore Science: HIPEC — The 'Cleaning Weapon' for Peritoneal Metastasis

HIPEC is a precise, deep-eradication technology for abdominal and peritoneal tumors. It continuously circulates a chemotherapy solution at a precisely maintained 42-43°C in the patient's abdominal cavity for 60-90 minutes.

The classic clinical model is CRS + HIPEC: Surgical removal of tumors is followed by our machine's constant-temperature, uniform, closed-loop perfusion. This double approach comprehensively eliminates residual free cancer cells and micron-level metastases that surgery alone cannot clear, substantially lowering recurrence risks and striving for long-term survival or clinical cure.

Department Introduction

Gastrointestinal and Hernia Surgery, Jinhua People's Hospital

Currently operating with 53 beds, the department boasts a highly qualified professional team (including 2 Chief Physicians, 3 Associate Chief Physicians, and multiple doctorates/masters). Centered around minimally invasive technology, it specializes in the precise treatment of gastrointestinal diseases, abdominal wall hernias, and inguinal hernias. It routinely performs advanced procedures like laparoscopic radical gastrectomy and colorectal resections, ranking at the forefront in the Jinhua area for surgical volume and variety. The department emphasizes fast recovery and day surgeries, ensuring 'worry-free gastrointestinal health' for the public.

Product Introduction

Cooper Medical Body Cavity Hyperthermic Perfusion Therapy MachineThis is a core minimally invasive device for treating malignant tumors and effusions in the thoracic and abdominal cavities.Precision Technology: Features advanced electromagnetic non-contact isolation heating and a ±0.3°C highprecision temperature control system to safely lock in the optimal 42-43°C tumor-killing temperature.Fourfold Treatment Mechanism: Combines hyperthermia, chemotherapy synergy, immune regulation, and mechanical washing to achieve safe, highly efficient targeted therapy while minimizing systemic toxicity.Design: Its compact, lightweight design allows for flexible bedside deployment and convenient operation.With its precise, safe, and highly efficient coreadvantages, it has become the preferred equipment for standardized minimally invasive tumor treatments across medical institutions at all levels, continually empowering clinical diagnostics and patient recovery.